• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性T细胞的CBM复合物/NF-κB与MAPK/P27信号通路之间的串扰有助于肿瘤微环境的形成。

Crosstalk between the CBM complex/NF-κB and MAPK/P27 signaling pathways of regulatory T cells contributes to the tumor microenvironment.

作者信息

Qi Tongbing, Luo Ying, Cui Weitong, Zhou Yue, Ma Xuan, Wang Dongming, Tian Xuewen, Wang Qinglu

机构信息

College of Sport and Health, Shandong Sport University, Jinan, China.

Key Laboratory of Biomedical Engineering and Technology of Shandong High School, Qilu Medical University, Zibo, China.

出版信息

Front Cell Dev Biol. 2022 Jul 19;10:911811. doi: 10.3389/fcell.2022.911811. eCollection 2022.

DOI:10.3389/fcell.2022.911811
PMID:35927985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9343696/
Abstract

Regulatory T cells (Tregs), which execute their immunosuppressive functions by multiple mechanisms, have been verified to contribute to the tumor microenvironment (TME). Numerous studies have shown that the activation of the CBM complex/NF-κB signaling pathway results in the expression of hypoxia-inducible factor-1 (HIF-1α) and interleukin-6 (IL-6), which initiate the TME formation. HIF-1α and IL-6 promote regulatory T cells (Tregs) proliferation and migration through the MAPK/CDK4/6/Rb and STAT3/SIAH2/P27 signaling pathways, respectively. IL-6 also promotes the production of HIF-1α and enhances the self-regulation of Tregs in the process of tumor microenvironment (TME) formation. In this review, we discuss how the crosstalk between the CARMA1-BCL10-MALT1 signalosome complex (CBM complex)/NF-κB and MAPK/P27 signaling pathways contributes to the formation of the TME, which may provide evidence for potential therapeutic targets in the treatment of solid tumors.

摘要

调节性T细胞(Tregs)通过多种机制发挥免疫抑制功能,已被证实对肿瘤微环境(TME)有影响。大量研究表明,CBM复合物/NF-κB信号通路的激活会导致缺氧诱导因子-1(HIF-1α)和白细胞介素-6(IL-6)的表达,从而启动TME的形成。HIF-1α和IL-6分别通过MAPK/CDK4/6/Rb和STAT3/SIAH2/P27信号通路促进调节性T细胞(Tregs)的增殖和迁移。IL-6还促进HIF-1α的产生,并在肿瘤微环境(TME)形成过程中增强Tregs的自我调节。在本综述中,我们讨论了CARMA1-BCL10-MALT1信号体复合物(CBM复合物)/NF-κB与MAPK/P27信号通路之间的相互作用如何促进TME的形成,这可能为实体瘤治疗中的潜在治疗靶点提供证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/5588ab92d2b2/fcell-10-911811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/359bde39f011/fcell-10-911811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/ec4c03138f3a/fcell-10-911811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/5588ab92d2b2/fcell-10-911811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/359bde39f011/fcell-10-911811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/ec4c03138f3a/fcell-10-911811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17b/9343696/5588ab92d2b2/fcell-10-911811-g003.jpg

相似文献

1
Crosstalk between the CBM complex/NF-κB and MAPK/P27 signaling pathways of regulatory T cells contributes to the tumor microenvironment.调节性T细胞的CBM复合物/NF-κB与MAPK/P27信号通路之间的串扰有助于肿瘤微环境的形成。
Front Cell Dev Biol. 2022 Jul 19;10:911811. doi: 10.3389/fcell.2022.911811. eCollection 2022.
2
Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.CARMA1-BCL10-MALT1-A20-NF-κB 在 T 细胞急性淋巴细胞白血病中的表达特征。
Eur J Med Res. 2014 Nov 11;19(1):62. doi: 10.1186/s40001-014-0062-8.
3
The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.钙依赖磷酸酶钙调神经磷酸酶在 T 细胞受体诱导 NF-κB 激活过程中控制 Carma1-Bcl10-Malt1 复合物的形成。
J Biol Chem. 2011 Mar 4;286(9):7522-34. doi: 10.1074/jbc.M110.155895. Epub 2011 Jan 3.
4
A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.A20 和 ABIN-1 在调节激活 T 细胞中 CBM 复合物触发的 NF-κB 信号转导中起协同作用。
Cell Mol Life Sci. 2022 Jan 31;79(2):112. doi: 10.1007/s00018-022-04154-z.
5
NOTCH1 Can Initiate NF-κB Activation via Cytosolic Interactions with Components of the T Cell Signalosome.NOTCH1 可通过与 T 细胞信号转导体组件的细胞质相互作用引发 NF-κB 激活。
Front Immunol. 2014 May 26;5:249. doi: 10.3389/fimmu.2014.00249. eCollection 2014.
6
Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome.由CARMA1-BCL10-MALT1信号小体介导的淋巴细胞信号传导与激活
Biol Chem. 2016 Dec 1;397(12):1315-1333. doi: 10.1515/hsz-2016-0216.
7
Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration.卡莱宾A靶向缺氧诱导因子-1α/核因子-κB信号通路以抑制结肠癌细胞迁移。
Front Pharmacol. 2023 Jul 31;14:1203436. doi: 10.3389/fphar.2023.1203436. eCollection 2023.
8
T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome.T 细胞受体信号向 NF-κB 的传递是通过细胞质 p62-Bcl10-Malt1-IKK 信号体来实现的。
Sci Signal. 2014 May 13;7(325):ra45. doi: 10.1126/scisignal.2004882.
9
Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.CARMA1/Bcl10/MALT1 信号体的结构架构:引发丝状体组装的成核作用。
Mol Cell. 2013 Sep 26;51(6):766-79. doi: 10.1016/j.molcel.2013.08.032.
10
MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.MALT1/副胱天蛋白酶是CARMA1下游的信号传导成分,介导T细胞受体诱导的核因子κB激活。
J Biol Chem. 2004 Apr 16;279(16):15870-6. doi: 10.1074/jbc.M310599200. Epub 2004 Jan 30.

引用本文的文献

1
Breaking the oncogenic link: BCL10-MALT1 disruption as a precision strike against NF-κB-driven lymphomas.打破致癌联系:破坏BCL10-MALT1作为对NF-κB驱动淋巴瘤的精准打击
Med Oncol. 2025 Jul 19;42(8):350. doi: 10.1007/s12032-025-02897-w.
2
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.了解 TNFR2 信号在乳腺癌肿瘤微环境中的作用。
J Exp Clin Cancer Res. 2024 Nov 28;43(1):312. doi: 10.1186/s13046-024-03218-1.
3
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions.

本文引用的文献

1
Mutation of PD-1 immune receptor tyrosine-based switch motif (ITSM) enhances the antitumor activity of cytotoxic T cells.程序性死亡受体1(PD-1)免疫受体酪氨酸转换基序(ITSM)的突变增强了细胞毒性T细胞的抗肿瘤活性。
Transl Cancer Res. 2020 Nov;9(11):6811-6819. doi: 10.21037/tcr-20-2118.
2
Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.天然免疫中的 Toll 样受体 (TLRs)、NOD 样受体 (NLRs) 和 RIG-I 样受体 (RLRs)。TLRs、NLRs 和 RLRs 配体作为造血疾病的免疫治疗药物。
Int J Mol Sci. 2021 Dec 13;22(24):13397. doi: 10.3390/ijms222413397.
3
胶质母细胞瘤的免疫检查点抑制剂:新兴科学、临床进展及未来方向。
J Neurooncol. 2025 Feb;171(3):531-547. doi: 10.1007/s11060-024-04881-2. Epub 2024 Nov 21.
4
NF-κB signaling pathway in tumor microenvironment.肿瘤微环境中的 NF-κB 信号通路。
Front Immunol. 2024 Oct 18;15:1476030. doi: 10.3389/fimmu.2024.1476030. eCollection 2024.
5
Gut microbiome and serum metabolome alterations associated with lactose intolerance (LI): a case‒control study and paired-sample study based on the American Gut Project (AGP).与乳糖不耐受(LI)相关的肠道微生物组和血清代谢组变化:基于美国肠道计划(AGP)的病例对照研究和配对样本研究。
mSystems. 2024 Oct 22;9(10):e0083924. doi: 10.1128/msystems.00839-24. Epub 2024 Sep 25.
6
Biological hypoxia in pre-transplant human pancreatic islets induces transplant failure in diabetic mice.移植前人类胰岛中的生物缺氧会导致糖尿病小鼠的移植失败。
Sci Rep. 2024 May 30;14(1):12402. doi: 10.1038/s41598-024-61604-3.
7
Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy.单细胞RNA测序揭示了骨肉瘤化疗前后的免疫微环境格局。
Heliyon. 2023 Dec 11;10(1):e23601. doi: 10.1016/j.heliyon.2023.e23601. eCollection 2024 Jan 15.
8
MALT1 accelerates proatherogenic vascular smooth muscle cell growth, invasion and synthetic phenotype switching via nuclear factor‑κB signaling‑dependent way.黏膜相关淋巴组织淋巴瘤易位蛋白1通过核因子-κB信号通路依赖性方式加速促动脉粥样硬化的血管平滑肌细胞生长、侵袭及合成表型转换。
Exp Ther Med. 2023 May 22;26(1):337. doi: 10.3892/etm.2023.12036. eCollection 2023 Jul.
Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13.
从嘌呤能受体 P2Y13 的角度评估肺腺癌的肿瘤微环境免疫调节和预后
Bioengineered. 2021 Dec;12(1):6286-6304. doi: 10.1080/21655979.2021.1971029.
4
The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4 T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.细胞周期蛋白依赖性激酶 8(CDK8)抑制剂 DCA 通过新型 CDK8-GATA3-FOXP3 通路促进 CD4 T 细胞的耐受性免疫表型。
Mol Cell Biol. 2021 Aug 24;41(9):e0008521. doi: 10.1128/MCB.00085-21.
5
The ERK mitogen-activated protein kinase signaling network: the final frontier in RAS signal transduction.ERK 丝裂原活化蛋白激酶信号网络:RAS 信号转导的终极前沿。
Biochem Soc Trans. 2021 Feb 26;49(1):253-267. doi: 10.1042/BST20200507.
6
Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data.黑色素瘤中的丝裂原活化蛋白激酶阻断:从临床前数据到临床数据,间歇性与连续治疗。
Curr Opin Oncol. 2021 Mar 1;33(2):127-132. doi: 10.1097/CCO.0000000000000706.
7
ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments.ZBTB7A是一种预后和免疫浸润的潜在生物标志物,基于生物信息学分析和实验,它可抑制子宫内膜癌的进展。
Cancer Cell Int. 2020 Nov 9;20(1):542. doi: 10.1186/s12935-020-01600-5.
8
The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease.CBM复合物:细胞功能、调控机制及其与人类疾病关联的多样性不断增加
Cell Immunol. 2020 Oct;356:104189. doi: 10.1016/j.cellimm.2020.104189. Epub 2020 Aug 1.
9
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.靶向代谢以改善肿瘤微环境用于癌症免疫治疗。
Mol Cell. 2020 Jun 18;78(6):1019-1033. doi: 10.1016/j.molcel.2020.05.034.
10
Endothelial Transient Receptor Potential Channels and Vascular Remodeling: Extracellular Ca Entry for Angiogenesis, Arteriogenesis and Vasculogenesis.内皮瞬时受体电位通道与血管重塑:细胞外钙内流在血管生成、动脉生成和血管发生中的作用
Front Physiol. 2020 Jan 21;10:1618. doi: 10.3389/fphys.2019.01618. eCollection 2019.